Impact of antiseizure medications on thyroid function in persons with epilepsy
Epilepsy & Behavior · 2026-08 · 181 · 111058
DOI: 10.1016/j.yebeh.2026.111058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsy & Behavior, 2026-08. Verfasst von Maraludevanapura Govindaiah Rohith und 7 weiteren Autor:innen. Beteiligte Einrichtung: R. Madhavan Nayar Center for Comprehensive Epilepsy Care, Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology,…. Hauptthemen laut MEDLINE: Anticonvulsants, Epilepsy, Hypothyroidism, Thyroid Gland. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Antiseizure medications (ASMs) are central to epilepsy management but may disrupt endocrine function, particularly thyroid homeostasis. Subclinical and central hypothyroidism are increasingly recognized among ASM users, yet routine thyroid monitoring remains uncommon. OBJECTIVE To evaluate the prevalence and patterns of thyroid dysfunction in epilepsy patients on ASMs and compare the impact of older versus newer ASMs on thyroid function. METHODS This cross-sectional study included 203 patients with epilepsy admitted to a tertiary epilepsy care centre in South India between July 2013 and March 2014. Patients with known thyroid disorders or other conditions affecting thyroid function were excluded. Thyroid function tests (TSH, fT3, fT4) were performed. Subclinical hypothyroidism was defined as elevated TSH with normal fT3/fT4; central hypothyroidism as low fT3/fT4 with normal or low TSH. ASMs were categorized into older and newer groups. Data were analysed using SPSS with appropriate parametric and non-parametric methods. RESULTS Subclinical hypothyroidism was found in 11.3% of patients, more common in generalized epilepsy (56.5%) than focal epilepsy (43.5%) (p = 0.005). Valproate and clonazepam were most frequently associated. Among patients on monotherapy, none on newer ASMs had subclinical hypothyroidism, whereas 14.9% on older ASMs were affected (p = 0.35). Central hypothyroidism occurred in 10.3%, predominantly among users of zonisamide, phenobarbital, oxcarbazepine, and clobazam. Both older and newer ASM groups showed similar central hypothyroidism rates (9.6% versus 9.1%) CONCLUSION: Both older and newer ASMs exert clinically significant effects on thyroid homeostasis. Older ASMs were more often linked to subclinical hypothyroidism, while central hypothyroidism risk was comparable across ASM types. Annual thyroid screening is recommended to detect dysfunction early and prevent metabolic and cardiovascular complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- R. Madhavan Nayar Center for Comprehensive Epilepsy Care, Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala 695011, India.
- R. Madhavan Nayar Center for Comprehensive Epilepsy Care, Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala 695011, India. Electronic address: drashalatha@sct…
Zitieren
APA
Rohith, M. G., Bharanidharan, G., Bhasi, A., Ram, N. A., Manisha, K. Y., Koshy, K. G., Menon, R. N., & Radhakrishnan, A. (2026). Impact of antiseizure medications on thyroid function in persons with epilepsy. Epilepsy & Behavior, 181, 111058. https://doi.org/10.1016/j.yebeh.2026.111058
Vancouver
Rohith MG, Bharanidharan G, Bhasi A, Ram NA, Manisha KY, Koshy KG, et al. Impact of antiseizure medications on thyroid function in persons with epilepsy. Epilepsy & Behavior. 2026;181:111058. doi:10.1016/j.yebeh.2026.111058
BibTeX
@article{Rohith2026,
author = {Rohith, Maraludevanapura Govindaiah and Bharanidharan, Gurumurthy and Bhasi, Ankith and Ram, Nadarajan Aravind and Manisha, K Y and Koshy, Kiren G and Menon, Ramshekhar N and Radhakrishnan, Ashalatha},
title = {Impact of antiseizure medications on thyroid function in persons with epilepsy},
journal = {Epilepsy & Behavior},
year = {2026},
volume = {181},
pages = {111058},
doi = {10.1016/j.yebeh.2026.111058}
}
EUVIMED